Suppr超能文献

合并症和并发症对新冠肺炎死亡率的影响:罗马尼亚西部的一项详细回顾性研究

The Effect of Comorbidities and Complications on COVID-19 Mortality: A Detailed Retrospective Study in Western Romania.

作者信息

Marc Monica Steluta, Rosca Daniela, Bratosin Felix, Fira-Mladinescu Ovidiu, Oancea Cristian, Pescaru Camelia Corina, Velescu Diana, Wellmann Norbert, Motofelea Alexandru Catalin, Ciuca Ioana Mihaiela, Saracin Karina, Manolescu Diana

机构信息

Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Department of Infectious Diseases, Discipline of Pulmonology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

出版信息

J Pers Med. 2023 Oct 29;13(11):1552. doi: 10.3390/jpm13111552.

Abstract

COVID-19 continues to impact global health systems even after being declared over, with some patients exhibiting severe complications linked to pre-existing conditions. This study aimed to investigate the association between comorbidities, complications, and survival outcomes among COVID-19 survivors in Western Romania. Our hypothesis posited that comorbidities and complications significantly influence survival rates. We conducted a retrospective analysis of 1948 COVID-19 survivors admitted from January to December 2021, with 192 selected for detailed analysis based on inclusion and exclusion criteria. The severity of COVID-19 was classified according to WHO guidelines, and conditions like hypertension and obesity were defined using criteria from the European Society of Hypertension (ESH), the European Society of Cardiology (ESC), and WHO, respectively. Among the 192 patients, 33 had mild, 62 had moderate, and 97 had severe COVID-19. The median age across the severity groups was 63.2 years. Patients undergoing tracheostomy had a mortality rate of 83.3% versus 22.2% for non-tracheostomy patients ( < 0.001) and presented with significantly higher lung injury, hospitalization duration, and complications. Remarkably, tracheostomized patients were 17.50 times more likely to succumb to the disease (95% CI 4.39-116.91, < 0.001). Furthermore, pneumothorax increased the mortality risk significantly (OR 22.11, 95% CI 5.72-146.03, < 0.001). Intriguingly, certain conditions like grade I hypertension and grade II obesity showed a protective effect against mortality, whereas type 2 diabetes mellitus increased mortality risk (univariate OR 2.89, = 0.001). The presence of certain comorbidities and complications significantly impacts the survival rates of COVID-19 patients in Western Romania. Notably, tracheostomy, pneumothorax, and T2DM were associated with increased mortality. This study underscores the importance of personalized patient care and provides insights for healthcare policymakers in Western Romania to improve clinical management strategies.

摘要

即使在宣布新冠疫情结束后,新冠病毒仍继续影响全球卫生系统,一些患者出现了与既往疾病相关的严重并发症。本研究旨在调查罗马尼亚西部新冠病毒幸存者的合并症、并发症与生存结果之间的关联。我们的假设是合并症和并发症会显著影响生存率。我们对2021年1月至12月收治的1948名新冠病毒幸存者进行了回顾性分析,根据纳入和排除标准选择了192名进行详细分析。新冠病毒的严重程度根据世界卫生组织指南进行分类,高血压和肥胖等疾病分别使用欧洲高血压学会(ESH)、欧洲心脏病学会(ESC)和世界卫生组织的标准进行定义。在这192名患者中,33例为轻症,62例为中症,97例为重症新冠病毒感染。各严重程度组的中位年龄为63.2岁。接受气管切开术的患者死亡率为83.3%,而非气管切开术患者为22.2%(<0.001),且肺部损伤、住院时间和并发症明显更高。值得注意的是,接受气管切开术的患者死于该疾病的可能性高出17.50倍(95%CI 4.39-116.91,<0.001)。此外,气胸显著增加了死亡风险(OR 22.11,95%CI 5.72-146.03,<0.001)。有趣的是,I级高血压和II级肥胖等某些疾病对死亡率有保护作用,而2型糖尿病则增加了死亡风险(单因素OR 2.89,=0.001)。某些合并症和并发症的存在显著影响罗马尼亚西部新冠病毒患者的生存率。值得注意的是,气管切开术、气胸和2型糖尿病与死亡率增加有关。本研究强调了个性化患者护理的重要性,并为罗马尼亚西部的医疗政策制定者改进临床管理策略提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a45c/10672588/4187258a6cb6/jpm-13-01552-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验